SHIRVANI, ALI MD
Urology · NPI 1528054046 · CARROLLTON, TX
SHIRVANI, ALI is a Urology in CARROLLTON, TX, a member of 1 medical group, who billed 37 distinct codes to Medicare Part B in 2024.
Groups: UROLOGY CLINICS OF NORTH TEXAS, PLLC (DALLAS, TX)
Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒
Provider overview · all codes · CY2024
All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.
Procedures billed to Medicare Part B (2024)
Medicare Part B FFS · CY2024 · as published by CMS| Code | Description | Services | Beneficiary-episodes | Avg charge | Avg Medicare payment |
|---|---|---|---|---|---|
| J1071 | Injection, testosterone cypionate, 1 mg | premium | premium | premium | premium |
| 81003 | Automated urinalysis test | premium | premium | premium | premium |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | premium | premium | premium | premium |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | premium | premium | premium | premium |
| 36415 | Insertion of needle into vein for collection of blood sample | premium | premium | premium | premium |
| 51798 | Ultrasound measurement of bladder capacity after voiding | premium | premium | premium | premium |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | premium | premium | premium | premium |
| 84153 | Psa (prostate specific antigen) measurement, total | premium | premium | premium | premium |
| 96372 | Injection of drug or substance under skin or into muscle | premium | premium | premium | premium |
| 87086 | Bacterial colony count, urine | premium | premium | premium | premium |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | premium | premium | premium | premium |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | premium | premium | premium | premium |
| 87481 | Detection test for candida species (yeast), amplified probe technique | premium | premium | premium | premium |
| 87088 | Bacterial urine culture | premium | premium | premium | premium |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | premium | premium | premium | premium |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | premium | premium | premium | premium |
| 99203 | New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| 87077 | Bacterial culture for aerobic isolates | premium | premium | premium | premium |
| 84403 | Testosterone (hormone) level, total | premium | premium | premium | premium |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | premium | premium | premium | premium |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | premium | premium | premium | premium |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | premium | premium | premium | premium |
| 87491 | Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique | premium | premium | premium | premium |
| 87496 | Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique | premium | premium | premium | premium |
| 87532 | Detection test by nucleic acid for herpes virus-6, amplified probe technique | premium | premium | premium | premium |
| 87556 | Detection test by nucleic acid for mycobacteria tuberculosis (tb bacteria), amplified probe technique | premium | premium | premium | premium |
| 87563 | Detection of mycoplasma genitalium by dna or rna probe | premium | premium | premium | premium |
| 87591 | Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique | premium | premium | premium | premium |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | premium | premium | premium | premium |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | premium | premium | premium | premium |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | premium | premium | premium | premium |
| 87661 | Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | premium | premium | premium | premium |
| 87511 | Detection test for gardnerella vaginalis (bacteria), amplified probe technique | premium | premium | premium | premium |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | premium | premium | premium | premium |
| 50590 | Shock wave crushing of kidney stones | premium | premium | premium | premium |
| 51700 | Simple bladder irrigation and/or instillation | premium | premium | premium | premium |
These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.